bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

bioRxiv/medRxiv Discussion Site Activity

Discussion Sites | TRiP Reviews

217 Discussion Links — NCRC — All Subjects

Most recent first Page 1: Articles 1-10  | Next

Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections
Taquet, M., Dercon, Q., Harrison, P. J.
10.1101/2021.10.26.21265508 — Posted: 2021-10-26 — Discussion: 2021-12-30  NCRC
Prevalence and risk factors for in-school transmission of SARS-CoV-2 in Massachusetts K-12 public schools, 2020-2021
Nelson, S. B., Dugdale, C., Bilinski, A., Cosar, D., Pollock, N. L., Ciaranello, A. L.
10.1101/2021.09.22.21263900 — Posted: 2021-09-26 — Discussion: 2021-12-30  NCRC
Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After
Simon, M. A., Luginbuhl, R., Parker, R.
10.1101/2021.11.17.21263608 — Posted: 2021-11-18 — Discussion: 2021-12-30  NCRC
Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021
Salvatore, P. P., Lee, C. C., Sleweon, S., McCormick, D. W., Nicolae, L., Knipe, K., Dixon, T., Banta, R., Ogle, I., Young, C., Dusseau, C., Salmonson, S., Ogden, C., Godwin, E., Ballom, T., Ross, T., Wynn, N. T., David, E., Bessey, T. K., Kim, G., Suppiah, S., Tamin, A., Harcourt, J. L., Sheth, M., Lowe, L., Browne, H., Tate, J. E., Kirking, H. L., Hagan, L. M.
10.1101/2021.11.12.21265796 — Posted: 2021-11-19 — Discussion: 2021-12-30  NCRC
SARS-CoV-2 reinfection trends in South Africa: analysis of routine surveillance data
Pulliam, J. R. C., van Schalkwyk, C., Govender, N., von Gottberg, A., Cohen, C., Groome, M. J., Dushoff, J., Mlisana, K., Moultrie, H.
10.1101/2021.11.11.21266068 — Posted: 2021-11-11 — Discussion: 2021-12-15  NCRC
Effect of COVID-19 vaccination on menstrual periods in a retrospectively recruited cohort
Male, V.
10.1101/2021.11.15.21266317 — Posted: 2021-11-15 — Discussion: 2021-12-15  NCRC
Quantitative measurement of infectious virus in SARS-CoV-2 Alpha, Delta and Epsilon variants reveals higher infectivity (viral titer:RNA ratio) in clinical samples containing the Delta and Epsilon variants.
Despres, H. W., Mills, M. G., Shirley, D. J., Schmidt, M. M., Huang, M.-L., Jerome, K. R., Greninger, A. L., Bruce, E. A.
10.1101/2021.09.07.21263229 — Posted: 2021-09-20 — Discussion: 2021-12-08  NCRC
SARS-CoV-2 infection in free-ranging white-tailed deer (Odocoileus virginianus)
Hale, V. L., Dennis, P. M., McBride, D. S., Nolting, J. M., Madden, C., Huey, D., Ehrlich, M., Grieser, J., Winston, J. A., Lombardi, D., Gibson, S., Saif, L., Killian, M. L., Lantz, K., Tell, R. M., Torchetti, M. K., Robbe-Austerman, S., Nelson, M. I., Faith, S. A., Bowman, A.
10.1101/2021.11.04.467308 — Posted: 2021-11-05 — Discussion: 2021-11-15  NCRC
COVID-19 vaccine effectiveness against hospitalizations and ICU admissions in the Netherlands, April- August 2021
de Gier, B., Kooijman, M., Kemmeren, J., de Keizer, N., Dongelmans, D., van Iersel, S. C. J. L., van de Kassteele, J., Andeweg, S. P., the RIVM COVID-19 epidemiology and surveillance team, , de Melker, H. E., Hahne, S. J. M., Knol, M. J., van den Hof, S.
10.1101/2021.09.15.21263613 — Posted: 2021-09-17 — Discussion: 2021-09-17  NCRC
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
Hoeg, T. B., Krug, A., Stevenson, J., Mandrola, J.
10.1101/2021.08.30.21262866 — Posted: 2021-09-08 — Discussion: 2021-08-30  NCRC

Evaluation Sources